Finance

Lists
600216:SHA
Zhejiang Medicine Co Ltd
CNÂ¥12.33
-1.75%
(-0.22) 1D
Sep 11, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600216...
Open
CNÂ¥12.44
High
CNÂ¥12.60
Low
CNÂ¥12.15
Mkt. cap
12.07B
Avg. vol.
32.46M
Volume
16.81M
Dividend
2.27%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
14.75
52-wk high
CNÂ¥18.58
52-wk low
CNÂ¥10.94
EPS
CNÂ¥0.84
Shares outstanding
965.26M
No. of employees
5K
Open
CNÂ¥12.44
High
CNÂ¥12.60
Low
CNÂ¥12.15
Mkt. cap
12.07B
Avg. vol.
32.46M
Volume
16.81M
Dividend
2.27%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 9, 2026
P/E ratio
14.75
52-wk high
CNÂ¥18.58
52-wk low
CNÂ¥10.94
EPS
CNÂ¥0.84
Shares outstanding
965.26M
No. of employees
5K
About Zhejiang Medicine Co Ltd
CEO-
Employees5.42K
FoundedMay 16, 1997
Headquarters-
SectorPharmaceutical industry
Websitezmc.top
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.37B
2.19B
2.19B
2.20B
Cost of goods sold
1.50B
1.80B
1.42B
1.33B
Cost of revenue
1.50B
1.80B
1.42B
1.33B
Research and development expenses
159.77M
106.60M
93.81M
152.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
349.18M
401.70M
336.15M
366.40M
Operating expense
494.12M
548.81M
437.74M
515.82M
Total operating expenses
1.99B
2.35B
1.86B
1.85B
Operating income
377.63M
-163.00M
330.27M
345.45M
Other non operating income
85.57M
-93.78M
-41.66M
-37.35M
EBT including unusual items
287.43M
-94.58M
306.45M
313.26M
EBT excluding unusual items
365.43M
-181.96M
304.24M
321.95M
Income tax expense
45.26M
11.92M
48.09M
56.06M
Effective tax rate
15.75%
-12.60%
15.69%
17.89%
Other operating expenses
-8.55M
37.06M
4.17M
375.41K
Net income
259.84M
-59.77M
287.01M
319.00M
Net profit margin
10.95%
-2.73%
13.10%
14.53%
Earnings per share
-
-
-
-
Interest and investment income
11.28M
6.19M
20.45M
13.85M
Interest expense
-6.44M
-6.35M
-4.82M
-
Net interest expenses
4.84M
-157.28K
15.62M
13.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
541.53M
14.46M
507.74M
521.50M
Gain or loss from assets sale
178.71K
81.15K
-
-18.70K
AI content may include mistakes. Learn more
Google apps